Ep 67 - Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Ep 67 - Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine
DeviceTalks Weekly
Ep 67 - Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Jul 23 2021 | 00:42:16

/
Episode 67 • July 23, 2021 • 00:42:16

Hosted By

Tom Salemi

Show Notes

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

Previous Episode

Ep 66 - Hear from the CEOs of two surgical robotics companies that together just raised over $1 billion

Next Episode

Ep 68 - What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

Other Episodes

November 07, 2025

Ep 263 - Medtronic’s Kowal describes an exciting future and new applications for cardiac pacing devices

In this episode of DeviceTalks Weekly, Host Tom Salem welcomes back Rob Kowal, MD, VP and general manager, cardiac pacing at Medtronic. You’ll hear...

Play

01:10:21

September 01, 2023

Ep 161 - CEO Nahum explains how Quantum Surgical is positioned for robotic surgery’s next evolutionary stage

This isn’t Bertin Nahum’s first surgical robotics rodeo. The CEO of Quantum Surgical previously co-founded, led and ultimately sold surgical robotics pioneer Medtech S.A....

Play

01:03:46

May 15, 2020

Ep 10 - How do medtech investors, CEOS manage portfolio companies going forward?

DeviceTalks Weekly: Ep. 10 – How do medtech investors, CEOS manage portfolio companies going forward? In this week’s episode of DeviceTalks Weekly, we talk...

Play

00:36:35